Bone Marrow-Derived Progenitor Cells Are Functionally Impaired in Ischemic Heart Disease
Open Access
- 25 July 2016
- journal article
- research article
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 9 (4) , 266-278
Abstract
To determine whether the presence of ischemic heart disease (IHD) per se, or rather the co-presence of heart failure (HF), is the primum movens for less effective stem cell products in autologous stem cell therapy, we assessed numbers and function of bone marrow (BM)-derived progenitor cells in patients with coronary artery disease (n = 17), HF due to ischemic cardiomyopathy (n = 8), non-ischemic HF (n = 7), and control subjects (n = 11). Myeloid and erythroid differentiation capacity of BM-derived mononuclear cells was impaired in patients with underlying IHD but not with non-ischemic HF. Migration capacity decreased with increasing IHD severity. Hence, IHD, with or without associated cardiomyopathy, is an important determinant of progenitor cell function. No depletion of hematopoietic and endothelial progenitor cells (EPC) within the BM was observed, while circulating EPC numbers were increased in the presence of IHD, suggesting active recruitment. The observed myelosuppression was not driven by inflammation and thus other mechanisms are at play.Keywords
Funding Information
- FWO Flanders (G060321N, Senior clinical investigator)
- University of Antwerp (Research grant)
This publication has 46 references indexed in Scilit:
- Quantification of circulating CD34+/KDR+/CD45dim endothelial progenitor cells: Analytical considerationsInternational Journal of Cardiology, 2013
- Diabetes Causes Bone Marrow Endothelial Barrier Dysfunction by Activation of the RhoA–Rho-Associated Kinase Signaling PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- Endothelial Progenitor Cell Dysfunction in Cardiovascular Diseases: Role of Reactive Oxygen Species and InflammationBioMed Research International, 2012
- Correlation between the functional impairment of bone marrow-derived circulating progenitor cells and the extend of coronary artery diseaseJournal of Translational Medicine, 2012
- Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart FailureJAMA, 2012
- Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptorsJournal of Experimental Medicine, 2011
- Contrasting effects of TNF and anti‐TNF on the activation of effector T cells and regulatory T cells in autoimmunityFEBS Letters, 2011
- Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challengesEuropean Heart Journal, 2011
- Aging and Disease as Modifiers of Efficacy of Cell TherapyCirculation Research, 2008
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008